D'Orazio & Associates, Inc. Bio Techne Corp Transaction History
D'Orazio & Associates, Inc.
- $655 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding TECH
# of Institutions
627Shares Held
160MCall Options Held
90KPut Options Held
14.2K-
Vanguard Group Inc Valley Forge, PA18.5MShares$924 Million0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$748 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.4MShares$567 Million0.08% of portfolio
-
State Street Corp Boston, MA6.53MShares$326 Million0.02% of portfolio
-
Morgan Stanley New York, NY5.72MShares$285 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $1.96B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...